Cue Biopharma Inc reports results for the quarter ended in June - Earnings Summary

Cue Biopharma

09/08/2021 22:55

* Cue Biopharma Inc  CUE.OQ  reported a quarterly adjusted loss
of 33 cents​​ per share for the quarter ended in June. The mean
expectation of five analysts for the quarter was for a loss
of 42 cents per share.
* Revenue rose 154.8% to $2.74 million from a year ago; 
analysts expected $1.06 million. 
* Cue Biopharma Inc's reported EPS for the quarter was a loss
of 33 cents​.
* The mean earnings estimate of analysts had fallen by
about 6.1% in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Cue Biopharma Inc shares had fallen by 8.0% this quarter and
lost 14.3% so far this year.
* The company reported a quarterly loss of $10.28 million.
* Wall Street's median 12-month price target for Cue Biopharma
Inc is $30.00 
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 6 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
This summary was machine generated August 9 at 09:55 p.m.  ​All
figures in US dollars unless otherwise stated